Vertex kidney drug Povetacicept succeeds in IgAN trial
A sign hangs in front of Vertex Pharmaceuticals' global headquarters in Boston. Brian Snyder | Reuters Vertex Pharmaceuticals said its…
health care industry
FDA approves leucovorin for brain folate deficiency, but not autism
The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a…
Novo Nordisk ends legal proceedings against Hims & Hers
Nordisk has dropped its legal case against telehealth provider him and her for patent infringement, after the two companies agreed…
In the fight against cystic fibrosis, Boomer Esiason and his son Gunnar win
When NFL quarterback Boomer Esiason was about to walk onto the New York Jets' practice field in 1993, shortly after…
Inside the booming business of wellness clubs and third spaces
A few years ago, Grace Guo began longing for places in New York City where going out with friends didn't…
FDA Vaccine Director to Resign in April After Series of Controversial Decisions
The Food and Drug Administration logo before a news conference at Health and Human Services Headquarters in Washington, April 22,…
FDA Reversals on UniQure, Moderna Approvals Worry Investors
Investors are concerned about the fate of multiple experimental drugs for difficult-to-treat diseases following a series of recent rejections by…
We're dipping into our deep pockets of cash to buy more of this type of healthcare stock.
We are buying 90 shares of Cardinal Health at approximately $217. Following the transaction, Jim Cramer's Charitable Trust will own…
Eli Lilly Launches Program to Increase Employer Coverage of Obesity Drugs
Eli Lilly On Thursday it launched a new program designed to help more employers cover obesity medications in the U.S.,…
We have been active in trading during the aftermath of the Iran war. Jim Cramer explains our approach
Jim Cramer explained Tuesday morning why the Investment Club is trying to strike a delicate balance with its moves during…